Michael Amoroso
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
Michael Amoroso is President, Chief Executive Officer & Director at Precision BioSciences, Inc. since 2021.
Formerly, Mr. Amoroso was Chairman at Abeona Therapeutics, Inc. from 2021 to 2026, Senior Vice President-Americas at Eisai, Inc. from 2017 to 2018, and SVP & Head-Cell Therapy Worldwide Commercial at Kite Pharma, Inc. from 2018 to 2020.
Education includes undergraduate studies at Rider University and an MBA from The Leonard N Stern School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 243 392 ( 1,01 % ) | 2 M $ | 31/05/2026 | |
| 15/04/2026 | 217 779 ( 0,38 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Directeur Général | 15/10/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Directeur Général | 14/10/2021 |
| KITE PHARMA INC | Corporate Officer/Principal | 01/01/2020 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01/08/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Precision BioSciences, Inc.
Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Rider University
Rider University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national